The main purpose of this legislation is to establish stricter regulations around the abortion drug mifepristone, also known as Mifeprex or RU-486. The law aims to reinstate a risk evaluation and mitigation strategy that was previously approved in 2011, which is intended to ensure the safe use of this medication. Key provisions of the law include a requirement for the Secretary of Health and Human Services to withdraw the current risk evaluation strategy for mifepristone and replace it with the 2011 version within 90 days of the law's enactment.